Raras
Buscar doenças, sintomas, genes...
Epilepsia do lobo temporal mesial com esclerose do hipocampo
ORPHA:99701CID-10 · G40.0PCDT · SUSDOENÇA RARA

No campo da neurologia, a epilepsia do lobo temporal é um distúrbio cerebral permanente que causa convulsões não provocadas no lobo temporal. A epilepsia do lobo temporal é o tipo mais comum de epilepsia de início focal em adultos. Os sintomas e o comportamento das crises distinguem as crises originadas no lobo temporal medial das crises originadas no lobo temporal lateral (neocortical). O diagnóstico depende de estudos eletroencefalográficos (EEG) e de neuroimagem. Medicamentos anticonvulsivantes, cirurgia de epilepsia e tratamentos dietéticos podem melhorar o controle das crises.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Epilepsia do lobo temporal mesial com esclerose do hipocampo é uma forma comum de epilepsia focal, caracterizada por crises epilépticas originadas no hipocampo, frequentemente associada a alterações estruturais (esclerose) nesta região cerebral.

Pesquisas ativas
1 ensaio
1 total registrados no ClinicalTrials.gov
Publicações científicas
199 artigos
Último publicado: 2026 Apr 15
🏥
SUS: Cobertura parcialScore: 45%
PCDT disponívelCID-10: G40.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico199PubMed
Últimos 10 anos126publicações
Pico202216 papers
Linha do tempo
2026Hoje · 2026🧪 2019Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Epilepsia do lobo temporal mesial com esclerose do hipocampo

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

1 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
129 papers (10 anos)
#1

Ablation of Unilateral Hippocampal GABAergic Neurons: A Novel Mouse Model of Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis.

CNS neuroscience & therapeutics2026 Feb

While various animal models of mesial temporal lobe epilepsy (MTLE) exist, a validated model based solely on hippocampal GABAergic interneuron loss is lacking. We aimed to establish and characterize a novel MTLE with hippocampal sclerosis (HS) model by selective ablation of these neurons. Using AAV vectors (flex-DTA or DIO-taCasp3-TEVp), we performed unilateral, partial ablation of GABAergic neurons in the dentate gyrus (DG) or CA1 subregions of VGAT-Cre mice. Spontaneous recurrent seizures (SRS) were monitored by video-EEG. Behavioral tests and histopathological analyses were conducted to assess comorbidities and HS features. DG-ablated mice all developed SRS, whereas 50%-70% of CA1-ablated mice did. Lethal SRS occurred in around 50% of DG-ablated mice. Both ablation models exhibited sustained SRS from Days 8-28, distinct from kainic acid model severity in some parameters. The model recapitulated anxiety-like behaviors, cognitive deficits, and hallmark HS pathology including gliosis, granule cell dispersion, and mossy fiber sprouting. Selective unilateral hippocampal GABAergic interneuron loss is sufficient to drive chronic epilepsy with HS. This model provides direct causal evidence and a precise platform for investigating MTLE-HS mechanisms and therapies.

#2

Influence of epilepsy syndrome on cancer comorbidity.

Epilepsy & behavior : E&B2026 Apr

The relationship between specific epilepsy syndromes and cancer is unclear. We aimed to analyze cancer frequency and its patterns in adults with Idiopathic Generalized Epilepsies (IGE) and Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis (MTLE-HS). We retrospectively studied 719 adults (471 IGE; 248 MTLE-HS) followed at a tertiary epilepsy clinic (2016-2023). Data included demographics, epilepsy characteristics, antiseizure medications (ASM), and oncological history, excluding intracranial tumors. Cancer occurred in 4.9% of IGE and 12.9% of MTLE-HS patients (p < 0.001); however, this difference disappeared after age adjustment. Endocrine tumors predominated in IGE (p = 0.031), whereas hematologic malignancies, exclusively of the B-cell lineage, were more common in MTLE-HS (p = 0.033). Five patients (1 IGE; 4 MTLE-HS) developed skin squamous cell carcinoma after long-term sodium channel blocker therapy. Our findings reveal different, syndrome-specific associations between epilepsy and cancer types, likely reflecting a shared genetic susceptibility, with convergent dysregulated immune pathways potentially underlying these patterns. Understanding these relationships may offer insights into pathophysiology and guide the prevention of cancer comorbidities in these patients.

#3

Hippocampal Gene Expression in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis: Assessment of Human Herpesvirus 6B DNA Status.

Journal of medical virology2026 Feb

Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is an intractable form of epilepsy involving the hippocampus, and temporal lobectomy remains an effective treatment. Human herpesvirus 6B (HHV-6B) establishes latency in the hippocampus and may contribute to MTLE-HS pathogenesis by altering host gene expression; however, transcriptomic data from healthy controls remain limited. This study investigated the role of HHV-6B to MTLE-HS pathogenesis by analyzing gene expression in resected hippocampal tissues. Samples were collected from 12 to 43 HHV-6 DNA-positive and -negative patients, respectively, and three controls. RNA sequencing was performed on eight representative samples, followed by RT-qPCR validation of nine selected genes in 58 samples. RNA sequencing identified 600 differentially expressed genes (210 upregulated, 390 downregulated) between HHV-6B-positive MTLE-HS and controls. Pathway enrichment analysis revealed involvement of synaptic signaling and inflammatory responses, with prostaglandin biosynthesis specifically upregulated in HHV-6B-positive tissues. Two genes were significantly upregulated in HHV-6B-positive compared with HHV-6B-negative samples. RT-qPCR confirmed elevated cholesterol 25-hydroxylase and interleukin 1 beta expression in HHV-6 DNA-positive samples (both p = 0.031). These findings suggest that HHV-6B may contribute to MTLE-HS pathogenesis by modulating the expression of host inflammatory genes, supporting a role for neuroinflammation and the potential benefits of anti-inflammatory therapies.

#4

Volumetric MRI study of the brain in patients with neurocysticercosis and mesial temporal lobe epilepsy.

Epileptic disorders : international epilepsy journal with videotape2026 Feb

Neurocysticercosis (NCC) is a common parasitic infection of the central nervous system and a known cause of focal epilepsy. Its potential role in triggering or contributing to mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is suggested, but the impact on brain volumetry remains unclear. This study aimed to assess volumetric differences in the brain, with a particular focus on the hippocampus and temporal lobes, in patients with NCC, MTLE, MTLE-HS, and their combinations. This was an observational, cross-sectional, retrospective, single-center exploratory study including five groups: healthy controls; isolated MTLE; isolated NCC; MTLE-HS; and MTLE-HS combined with NCC (MTLE-HS plus NCC). All participants had at least one magnetic resonance imaging (MRI) examination suitable for volumetric post-processing. Volumetric analysis was performed on cerebral cortex regions (frontal, parietal, temporal, and occipital lobes), cerebellum, total and white matter limbic system, amygdala, hippocampus, and thalamus using the T1 MultiAtlas Segmentation tool (Brain GPS©). We also assessed sensitivity by estimating the minimum detectable difference from adjusted models and performed an exploratory analysis of NCC lesion topography with Welch t-tests on lobar/subcortical volumes. After adjusting for age and sex, no significant group differences were found in hippocampal or temporal lobe volumetrics (all p > .10). Effect sizes were small (partial η2 ≤ .10), and MANOVA confirmed the absence of a global effect (Pillai's Trace = .114, p = .623). Adjusted means showed only modest variation with overlapping confidence intervals, indicating that differences likely reflect individual variability rather than systematic group effects. The findings indicate that NCC, whether isolated or combined with MTLE-HS, does not cause significant alterations in brain volume. This suggests the absence of an additive or synergistic effect of NCC on brain morphostructural changes in patients with MTLE-HS. These results contribute to understanding the pathophysiology of epilepsy related to NCC and hippocampal sclerosis, supporting that volumetric brain changes may not underlie their association.

#5

The interacting etiologies of hippocampal sclerosis in epilepsy: A scoping review.

Epilepsia2026 Feb

According to the International League Against Epilepsy classification, mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is considered an epilepsy syndrome. Several etiologies may precede HS, but there is little overview in the literature about these etiologies. We conducted a scoping review to systematically search, select, analyze, and synthesize the existing knowledge about the etiology of HS in patients with epilepsy. MEDLINE, Embase, Web of Science Core Collection, and Cochrane Library were searched using a systematic search strategy. Relevant data were selected according to strict criteria. A bibliometric analysis was done by VOSviewer software. A total of 907 studies were selected and classified. The main classes of etiologies we found are prolonged (febrile) seizures, genetic predisposition, infection, autoimmunity, trauma, neurodegeneration, developmental aspects, toxins (e.g., domoic acid), and hypertensive events (e.g., Posterior reversible encephalopathy syndrome), with several interactions between different etiologies. Autoimmunity and neurodegeneration were the most recently described etiologies. We found that the etiology of MTLE-HS is complex, with several risk factors influencing susceptibility and a heterogenous pathophysiology between patients. Future, prospective studies addressing the interactions of these etiologies in the development of HS are warranted. A better understanding of the interacting etiologies of MTLE-HS could have a major impact on the development of more precise diagnostic biomarkers, preventive strategies, and treatment options for this epilepsy syndrome.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC121 artigos no totalmostrando 126

2026

Influence of epilepsy syndrome on cancer comorbidity.

Epilepsy &amp; behavior : E&amp;B
2026

Hippocampal Gene Expression in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis: Assessment of Human Herpesvirus 6B DNA Status.

Journal of medical virology
2026

Ablation of Unilateral Hippocampal GABAergic Neurons: A Novel Mouse Model of Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis.

CNS neuroscience &amp; therapeutics
2025

Mesial temporal lobe epilepsy with hippocampal sclerosis: Seizure, neuropsychological, and quality of life outcomes of 100 patients treated with trans-anterior T1 selective amygdalohippocampectomy.

Epileptic disorders : international epilepsy journal with videotape
2026

Volumetric MRI study of the brain in patients with neurocysticercosis and mesial temporal lobe epilepsy.

Epileptic disorders : international epilepsy journal with videotape
2026

The interacting etiologies of hippocampal sclerosis in epilepsy: A scoping review.

Epilepsia
2025

Long-term seizure outcomes of epilepsy surgery in patients with mesial temporal lobe epilepsy caused by hippocampal sclerosis based on preoperative ictal versus non-ictal video-EEG: A 10-year follow-up.

Epilepsy &amp; behavior : E&amp;B
2025

Mesial temporal lobe epilepsy with hippocampal sclerosis: comparative clinical and arterial spin labeling findings according to neocortical MRI changes.

Neuroradiology
2025

Twins with temporal lobe epilepsy: genetic contributions to hippocampal sclerosis and other subtypes.

Brain : a journal of neurology
2025

Treatment-resistant patients with focal epilepsy of unknown cause display reduced neurogranin levels: a preliminary study.

Ideggyogyaszati szemle
2024

Differences and potential mechanisms of theta oscillation and temporoparietal and temporal-central networks in temporal lobe epilepsy patients with unilateral hippocampal sclerosis.

Acta epileptologica
2025

Verbal Memory Localized in Non-language-dominant Hemisphere: Atypical Lateralization Revealed by Material-specific Memory Evaluation Using Super-selective Wada Test.

NMC case report journal
2025

[Efficacy and safety of stereoelectroencephalography-guided 3D radiofrequency thermocoagulation for the treatment of drug-resistant medial temporal lobe epilepsy with hippocampal sclerosis].

Zhonghua yi xue za zhi
2025

Subunit specific altered expression and activity of casein kinase 2 in the brain tissues resected from mesial temporal lobe epilepsy with hippocampal sclerosis patients & rodent temporal lobe epilepsy model.

Neuroscience
2025

Pathology-specific lipid alterations with triacylglycerol as a potential biomarker in Focal cortical dysplasia (FCD) and Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis (MTLE-HS).

Neuroscience
2025

Brain Hypertrophy in Patients With Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis and Its Clinical Correlates.

Neurology
2024

Distinguishing seizures in autoimmune limbic encephalitis from mesial temporal lobe epilepsy with hippocampal sclerosis: Clues of a temporal plus network.

Journal of the neurological sciences
2024

Somatic variants as a cause of drug-resistant epilepsy including mesial temporal lobe epilepsy with hippocampal sclerosis.

Epilepsia
2024

Postsurgical Outcomes of Mesial Temporal Lobe Epilepsy due to Hippocampal Sclerosis Associated with Calcified Neurocysticercosis.

The American journal of tropical medicine and hygiene
2024

Long-term outcome of treatment-naïve patients with mesial temporal lobe epilepsy with hippocampal sclerosis: A retrospective study in a single center.

Seizure
2023

Combined Depth and Subdural Electrodes for Lateralization of the Ictal Onset Zone in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis.

Brain sciences
2024

Stereo-electroencephalography-guided three-dimensional radiofrequency thermocoagulation for mesial temporal lobe epilepsy with hippocampal sclerosis: A retrospective study with long-term follow-up.

Epilepsia open
2023

Referral odyssey plot to visualize causes of surgical delay in mesial temporal lobe epilepsy with hippocampal sclerosis.

Epilepsy &amp; behavior : E&amp;B
2023

Performance of hippocampal radiomics models based on T2-FLAIR images in mesial temporal lobe epilepsy with hippocampal sclerosis.

European journal of radiology
2023

The CA2 hippocampal subfield in humans: A review.

Hippocampus
2023

Different relationships between epilepsy syndromes and autoimmune diseases.

Epileptic disorders : international epilepsy journal with videotape
2023

Morphometric and microstructural characteristics of hippocampal subfields in mesial temporal lobe epilepsy and their correlates with mnemonic discrimination.

Frontiers in neurology
2022

The comparison of decision-making in ambiguous situations and galvanic skin responses as somatic markers in patients with posterior cortex epilepsy and mesial temporal lobe epilepsy with hippocampal sclerosis.

Journal of clinical and experimental neuropsychology
2023

Early identification of seizure freedom with medical treatment in patients with mesial temporal lobe epilepsy and hippocampal sclerosis.

Journal of neurology
2022

Circulating cell-free DNA methylation mirrors alterations in cerebral patterns in epilepsy.

Clinical epigenetics
2023

Novel variants in GABAA receptor subunits: A possible association with benzodiazepine resistance in patients with drug-resistant epilepsy.

Epilepsy research
2022

Mesial Temporal Lobe Epilepsy (MTLE) Drug-Refractoriness Is Associated With P2X7 Receptors Overexpression in the Human Hippocampus and Temporal Neocortex and May Be Predicted by Low Circulating Levels of miR-22.

Frontiers in cellular neuroscience
2022

MicroRNAs miR-629-3p, miR-1202 and miR-1225-5p as potential diagnostic and surgery outcome biomarkers for mesial temporal lobe epilepsy with hippocampal sclerosis.

Neuro-Chirurgie
2022

Prompting endogenous repair of brain injury: science fiction or reality?

Molecular neurodegeneration
2022

Hippocampal Cytokine Release in Experimental Epileptogenesis-A Longitudinal In Vivo Microdialysis Study.

Brain sciences
2022

SCN1A overexpression, associated with a genomic region marked by a risk variant for a common epilepsy, raises seizure susceptibility.

Acta neuropathologica
2022

International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions.

Epilepsia
2022

Lateralizing Characteristics of Morphometric Changes to Hippocampus and Amygdala in Unilateral Temporal Lobe Epilepsy with Hippocampal Sclerosis.

Medicina (Kaunas, Lithuania)
2022

The Potential of Circulating Cell-Free DNA Methylation as an Epilepsy Biomarker.

Frontiers in cellular neuroscience
2022

Kv5.1 antibody in epilepsy patients with unknown etiology.

Epilepsy research
2022

Benchmarking the proteomic profile of animal models of mesial temporal epilepsy.

Annals of clinical and translational neurology
2022

Interhemispheric functional connectivity asymmetry is distinctly affected in left and right mesial temporal lobe epilepsy.

Brain and behavior
2021

Evaluating the Association of Calcified Neurocysticercosis and Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis in a Large Cohort of Patients With Epilepsy.

Frontiers in neurology
2022

Cytokine-chemokine profiles in the hippocampus of patients with mesial temporal lobe epilepsy and hippocampal sclerosis.

Epilepsy research
2022

Epilepsy progression is associated with cumulative DNA methylation changes in inflammatory genes.

Progress in neurobiology
2021

Multidimensional Approach Assessing the Role of Interleukin 1 Beta in Mesial Temporal Lobe Epilepsy.

Frontiers in neurology
2021

Let there be light: Inhibitory effect of photic stimulation on spike frequency in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.

Epilepsy research
2021

Differential regulation of excitatory synaptic transmission in the hippocampus and anterior temporal lobe by cyclin dependent kinase 5 (Cdk5) in mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS).

Neuroscience letters
2021

Stereotactic EEG-guided radiofrequency thermocoagulation versus anterior temporal lobectomy for mesial temporal lobe epilepsy with hippocampal sclerosis: study protocol for a randomised controlled trial.

Trials
2021

Female preponderance in genetic generalized epilepsies.

Seizure
2021

Headache in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.

Epilepsy &amp; behavior : E&amp;B
2021

Altered hippocampal kynurenine pathway metabolism contributes to hyperexcitability in human mesial temporal lobe epilepsy-hippocampal sclerosis.

British journal of pharmacology
2021

Association of hypometabolic extension of 18F-FDG PET with diffusion tensor imaging indices in mesial temporal lobe epilepsy with hippocampal sclerosis.

Seizure
2021

Multi-omics in mesial temporal lobe epilepsy with hippocampal sclerosis: Clues into the underlying mechanisms leading to disease.

Seizure
2023

The Thalamic and Intracortical Inhibitory Function of Somatosensory System Is Unchanged in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
2021

Ictal fear is associated with anxiety symptoms and interictal dysphoric disorder in drug-resistant mesial temporal lobe epilepsy.

Epilepsy &amp; behavior : E&amp;B
2020

"Benign" temporal lobe epilepsy with hippocampal sclerosis: A forgotten entity?

Epilepsy &amp; behavior reports
2020

Differential Glial Activation in Early Epileptogenesis-Insights From Cell-Specific Analysis of DNA Methylation and Gene Expression in the Contralateral Hippocampus.

Frontiers in neurology
2022

Role of Altered Expression, Activity and Sub-cellular Distribution of Various Histone Deacetylases (HDACs) in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis.

Cellular and molecular neurobiology
2020

Plasma Exosomal MiRNAs Expression Profile in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis: Case-Control Study and Analysis of Potential Functions.

Frontiers in molecular neuroscience
2020

Abnormalities of Cortical Thickness in Pediatric Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis.

Current medical imaging
2021

Electrical Stimulation of Subiculum for the Treatment of Refractory Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis: A 2-Year Follow-Up Study.

Stereotactic and functional neurosurgery
2020

α7 nicotinic receptors contributes to glutamatergic activity in the hippocampus of patients with mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS).

Journal of neural transmission (Vienna, Austria : 1996)
2020

Peripheral blood expression levels of inflammasome complex components in two different focal epilepsy syndromes.

Journal of neuroimmunology
2020

Expression of circulating microRNAs as predictors of diagnosis and surgical outcome in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.

Epilepsy research
2020

VIP Modulation of Hippocampal Synaptic Plasticity: A Role for VIP Receptors as Therapeutic Targets in Cognitive Decline and Mesial Temporal Lobe Epilepsy.

Frontiers in cellular neuroscience
2020

Modulation of NMDA receptor by miR-219 in the amygdala and hippocampus of patients with mesial temporal lobe epilepsy.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2020

On brain atlas choice and automatic segmentation methods: a comparison of MAPER & FreeSurfer using three atlas databases.

Scientific reports
2020

Social impairment and stigma in genetic generalized epilepsies.

Epilepsy &amp; behavior : E&amp;B
2019

Optimized SEEG-guided radiofrequency thermocoagulation for mesial temporal lobe epilepsy with hippocampal sclerosis.

Seizure
2019

Expression of MicroRNAs miR-145, miR-181c, miR-199a and miR-1183 in the Blood and Hippocampus of Patients with Mesial Temporal Lobe Epilepsy.

Journal of molecular neuroscience : MN
2020

Voxel-based morphometry analysis and machine learning based classification in pediatric mesial temporal lobe epilepsy with hippocampal sclerosis.

Brain imaging and behavior
2019

Investigation of Generalized EEG Paroxysms Accompanying Focal Epilepsies.

Clinical EEG and neuroscience
2019

The Dilemma of the Chicken or the Egg-What Appears First in TLE-Seizures or Morphometric Changes in the Temporal Lobe?

Epilepsy currents
2019

Transcriptomic and genetic analyses reveal potential causal drivers for intractable partial epilepsy.

Brain : a journal of neurology
2019

Follow-up of patients with epilepsy harboring antiglycine receptor antibodies.

Epilepsy &amp; behavior : E&amp;B
2019

Hospital Anxiety and Depression Scale-Anxiety subscale (HADS-A) and The State-Trait Anxiety Inventory (STAI) accuracy for anxiety disorders detection in drug-resistant mesial temporal lobe epilepsy patients.

Journal of affective disorders
2018

Commentary on Nóbrega-Jr et al. "Mesial temporal lobe epilepsy with hippocampal sclerosis is infrequently associated with neuronal antibodies".

Epilepsia
2018

Is self-report sleepiness associated with cognitive performance in temporal lobe epilepsy?

Arquivos de neuro-psiquiatria
2019

Abnormal temporal lobe morphology in asymptomatic relatives of patients with hippocampal sclerosis: A replication study.

Epilepsia
2018

Mesial temporal lobe epilepsy with hippocampal sclerosis is infrequently associated with neuronal autoantibodies.

Epilepsia
2018

Symmetric tract-based spatial statistics of patients with left versus right mesial temporal lobe epilepsy with hippocampal sclerosis.

Neuroreport
2018

Rare variants and de novo variants in mesial temporal lobe epilepsy with hippocampal sclerosis.

Neurology. Genetics
2018

Correlation of neuropsychological and metabolic changes after epilepsy surgery in patients with left mesial temporal lobe epilepsy with hippocampal sclerosis.

EJNMMI research
2018

Morphometric MRI features and surgical outcome in patients with epilepsy related to hippocampal sclerosis and low intellectual quotient.

Epilepsy &amp; behavior : E&amp;B
2018

New clinicopathological associations and histoprognostic markers in ILAE types of hippocampal sclerosis.

Brain pathology (Zurich, Switzerland)
2018

Meta-analysis of voxel-based morphometry studies of gray matter abnormalities in patients with mesial temporal lobe epilepsy and unilateral hippocampal sclerosis.

Brain imaging and behavior
2018

Predictive value of preoperative statistical parametric mapping of regional glucose metabolism in mesial temporal lobe epilepsy with hippocampal sclerosis.

Epilepsy &amp; behavior : E&amp;B
2017

Parahippocampal Involvement in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis: A Proof of Concept from Memory-Guided Saccades.

Frontiers in neurology
2017

Brain expression of inflammatory mediators in Mesial Temporal Lobe Epilepsy patients.

Journal of neuroimmunology
2018

Volumetric Changes in Hippocampal Subregions and Memory Performance in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis.

Neuroscience bulletin
2018

[Clinical and pathological definition of temporal medium epilepsy subtypes with hypocampic sclerosis].

Neurocirugia
2017

Pharmacoresistance with newer anti-epileptic drugs in mesial temporal lobe epilepsy with hippocampal sclerosis.

Epilepsy research
2017

Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.

Epilepsia
2017

MicroRNA and mesial temporal lobe epilepsy with hippocampal sclerosis: Whole miRNome profiling of human hippocampus.

Epilepsia
2018

Immunogenetic predisposing factors for mesial temporal lobe epilepsy with hippocampal sclerosis.

The International journal of neuroscience
2016

Evaluation of Glutamic Acid Decarboxylase Antibody Levels in Patients with Juvenile Myoclonic Epilepsy and Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis.

Noro psikiyatri arsivi
2016

Brain Infiltration of Immune Cells in CASPR2-Antibody Associated Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis.

Noro psikiyatri arsivi
2017

Morphometric MRI features are associated with surgical outcome in mesial temporal lobe epilepsy with hippocampal sclerosis.

Epilepsy research
2017

Short-term cerebral activity alterations after surgery in patients with unilateral mesial temporal lobe epilepsy associated with hippocampal sclerosis: A longitudinal resting-state fMRI study.

Seizure
2017

Hippocampal Atrophy Is Associated with Altered Hippocampus-Posterior Cingulate Cortex Connectivity in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis.

AJNR. American journal of neuroradiology
2017

Electrophysiological resting-state biomarker for diagnosing mesial temporal lobe epilepsy with hippocampal sclerosis.

Epilepsy research
2016

Combined 18F-FDG-PET and diffusion tensor imaging in mesial temporal lobe epilepsy with hippocampal sclerosis.

NeuroImage. Clinical
2017

Altered microRNA profiles in plasma exosomes from mesial temporal lobe epilepsy with hippocampal sclerosis.

Oncotarget
2017

Age of onset of mesial temporal lobe epilepsy with hippocampal sclerosis: the effect of apolipoprotein E and febrile seizures.

The International journal of neuroscience
2016

Hippocampal atrophy on MRI is predictive of histopathological patterns and surgical prognosis in mesial temporal lobe epilepsy with hippocampal sclerosis.

Epilepsy research
2016

1H-MRS metabolite's ratios show temporal alternation in temporal lobe seizure: Comparison between interictal and postictal phases.

Epilepsy research
2016

Clinical and electrophysiological findings in mesial temporal lobe epilepsy with hippocampal sclerosis, based on the recent histopathological classifications.

Epilepsy research
2016

The effect of transcranial direct current stimulation on seizure frequency of patients with mesial temporal lobe epilepsy with hippocampal sclerosis.

Clinical neurology and neurosurgery
2016

Age at onset and seizure frequency affect white matter diffusion coefficient in patients with mesial temporal lobe epilepsy.

Epilepsy &amp; behavior : E&amp;B
2016

Mesial temporal lobe epilepsy with hippocampal sclerosis as a neuroimmunological disorder.

Journal of neurology, neurosurgery, and psychiatry
2016

Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis.

Journal of neurology, neurosurgery, and psychiatry
2016

Changes in Central Auditory Processing in Patients with Mesial Temporal Lobe Epilepsy after Anterior Temporal Lobectomy with Amygdalohippocampectomy.

Journal of clinical neurology (Seoul, Korea)
2016

Epilepsy diagnostic and treatment needs identified with a collaborative database involving tertiary centers in France.

Epilepsia
2016

More Severe Extratemporal Damages in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis Than That With Other Lesions: A Multimodality MRI Study.

Medicine
2015

Comparison of temporal lobe epilepsy with hippocampal sclerosis and temporal lobe epilepsies due to other etiologies.

Medical journal of the Islamic Republic of Iran
2015

Combined effect between two functional polymorphisms of SLC6A12 gene is associated with temporal lobe epilepsy.

Journal of genetics
2015

Volumetric and shape analysis of hippocampal subfields in unilateral mesial temporal lobe epilepsy with hippocampal atrophy.

Epilepsy research
2015

Neuroimaging observations linking neurocysticercosis and mesial temporal lobe epilepsy with hippocampal sclerosis.

Epilepsy research
2015

Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis.

Expert opinion on pharmacotherapy
2015

Gamma Knife radiosurgery for recurrent or residual seizures after anterior temporal lobectomy in mesial temporal lobe epilepsy patients with hippocampal sclerosis: long-term follow-up results of more than 4 years.

Journal of neurosurgery
2015

Neurocysticercotic Calcifications and Hippocampal Sclerosis: A Case-Control Study.

PloS one
2015

Validation of diagnostic tests for depressive disorder in drug-resistant mesial temporal lobe epilepsy.

Epilepsy &amp; behavior : E&amp;B
2015

Mesial temporal lobe epilepsy with hippocampal sclerosis is a network disorder with altered cortical hubs.

Epilepsia
2015

Memory outcome following left anterior temporal lobectomy in patients with a failed Wada test.

Epilepsy &amp; behavior : E&amp;B
2015

MTLE with hippocampal sclerosis in adult as a syndrome.

Revue neurologique

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Epilepsia do lobo temporal mesial com esclerose do hipocampo.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Epilepsia do lobo temporal mesial com esclerose do hipocampo

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Ablation of Unilateral Hippocampal GABAergic Neurons: A Novel Mouse Model of Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis.
    CNS neuroscience &amp; therapeutics· 2026· PMID 41618744mais citado
  2. Influence of epilepsy syndrome on cancer comorbidity.
    Epilepsy &amp; behavior : E&amp;B· 2026· PMID 41702218mais citado
  3. Hippocampal Gene Expression in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis: Assessment of Human Herpesvirus 6B DNA Status.
    Journal of medical virology· 2026· PMID 41696864mais citado
  4. Volumetric MRI study of the brain in patients with neurocysticercosis and mesial temporal lobe epilepsy.
    Epileptic disorders : international epilepsy journal with videotape· 2026· PMID 41235465mais citado
  5. The interacting etiologies of hippocampal sclerosis in epilepsy: A scoping review.
    Epilepsia· 2026· PMID 41104578mais citado
  6. Spatiotemporal dynamics of seizure networks: Progressive posterior hippocampal recruitment in mesial temporal lobe epilepsy.
    Epilepsia· 2026· PMID 41987574recente
  7. Transcriptional signatures and topological reorganization of morphometric similarity networks in temporal lobe epilepsy with unilateral hippocampal sclerosis.
    Epilepsia· 2026· PMID 41925386recente
  8. Impact of laterality on seizure duration in mesial temporal lobe epilepsy with hippocampal sclerosis.
    Epilepsy Behav Rep· 2026· PMID 41908687recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:99701(Orphanet)
  2. MONDO:0020476(MONDO)
  3. Epilepsia(PCDT · Ministério da Saúde)
  4. GARD:19684(GARD (NIH))
  5. Busca completa no PubMed(PubMed)
  6. Q55789414(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Epilepsia do lobo temporal mesial com esclerose do hipocampo
Compêndio · Raras BR

Epilepsia do lobo temporal mesial com esclerose do hipocampo

ORPHA:99701 · MONDO:0020476
🇧🇷 Brasil SUS
Geral
CID-10
G40.0 · Epilepsia e síndromes epilépticas idiopáticas definidas por sua localização (focal) (parcial) com crises de início focal
Ensaios
1 ativos
Início
Adolescent, Adult, Childhood, Elderly, Infancy
MedGen
UMLS
C4749367
Repurposing
14 candidatos
aminohydroxybutyric-acidcarbonic anhydrase inhibitor
diclofenamidesuccinimide antiepileptic
ethosuximideglutamate receptor antagonist
+11 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades